INTS1

INTS1 is the largest subunit and putative scaffold of the multi-subunit Integrator complex, which mediates endonucleolytic 3'-end processing of nascent UsnRNAs and ensures accurate transcriptional termination (PMID:17544522, PMID:23288851). Genetic disruption of INTS1 in mice arrests embryos at the blastocyst stage with apoptotic death in the inner cell mass and produces accumulation of unprocessed primary U2 snRNA with loss of mature U2, establishing a non-redundant role in snRNA 3'-end maturation (PMID:17544522). In Drosophila, a 45-residue N-terminal microdomain of IntS12 binds and stabilizes IntS1, and loss of this interaction abolishes snRNA processing activity, supporting INTS1 as the structural core around which the complex assembles (PMID:23288851). Beyond snRNA processing, INTS1 loss in zebrafish causes genome-wide transcriptional defects including first-intron retention and transcript readthrough extensions, reflecting roles in accurate termination and 3'-end formation across protein-coding genes (PMID:41424761). Through this transcriptional regulatory function the Integrator controls developmental gene programs: in Drosophila neural lineages IntS1 regulates the transcription factor earmuff in intermediate neural progenitors to suppress their dedifferentiation into neuroblasts (PMID:31018143). Biallelic truncating and missense mutations in human INTS1 cause a recessive neurodevelopmental syndrome with intellectual disability, absent speech, hypotonia, cataracts, and craniofacial anomalies (PMID:28542170, PMID:30622326), and zebrafish models recapitulate abnormal lens development and disrupted circadian/sleep behavior associated with altered noradrenergic gene expression (PMID:30622326, PMID:39189071).

1. 2006 Medium

   Whether the large INTS1 protein has an essential in vivo function was unknown; targeted disruption showed it is required for early development, establishing INTS1 as non-redundant.

   Evidence Gene-targeted knockout mice from a reverse-genetics screen of large KIAA proteins

   PMID:16807365

   Open questions at the time

   • No molecular mechanism for the lethality defined
   • Did not connect phenotype to a biochemical activity
2. 2007 High

   The molecular basis of INTS1's essential role was unresolved; knockout embryos linked its loss to failed U2 snRNA 3'-end processing and inner-cell-mass apoptosis, defining INTS1 as required for snRNA maturation.

   Evidence Knockout mouse embryos with TUNEL/caspase assays, qRT-PCR of unprocessed vs mature U2 snRNA, nuclear immunolocalization

   PMID:17544522

   Open questions at the time

   • Scaffold role inferred but not biochemically demonstrated
   • Effect on protein-coding gene transcription not assessed
3. 2013 High

   How INTS1 is incorporated into the Integrator was unknown; an IntS12 N-terminal microdomain was shown to bind and stabilize IntS1, positioning INTS1 as the assembly scaffold whose disruption abolishes snRNA processing.

   Evidence RNAi rescue, domain mutagenesis, co-IP and snRNA 3'-end processing reporter in Drosophila S2 cells

   PMID:23288851

   Open questions at the time

   • Structural basis of scaffolding not resolved
   • Stoichiometry and full subunit contacts unmapped
4. 2017 Medium

   Whether INTS1 dysfunction causes human disease was unknown; biallelic truncating mutations were tied to a recessive neurodevelopmental syndrome with the expected UsnRNA processing defect, linking Integrator activity to human transcriptome integrity.

   Evidence Patient exome sequencing, unprocessed UsnRNA analysis in patient cells, INTS8 genome editing with RNA-seq during neural differentiation

   PMID:28542170

   Open questions at the time

   • Molecular phenotype mainly demonstrated via INTS8 model rather than INTS1 directly
   • Tissue-specific basis of neurodevelopmental phenotype unclear
5. 2019 High

   The developmental processes affected by INTS1 loss were poorly defined; patient findings plus zebrafish and Drosophila models tied INTS1 to lens/eye development and to suppression of neural progenitor dedifferentiation via earmuff regulation.

   Evidence Exome sequencing, CRISPR zebrafish knockout with eye histology and in situ hybridization; Drosophila INP-specific RNAi, DamID, and genetic epistasis

   PMID:30622326 PMID:31018143

   Open questions at the time

   • Direct transcriptional targets in vertebrate eye not identified
   • Mechanism linking snRNA processing to earmuff regulation not fully resolved
6. 2024 Medium

   Whether INTS1 contributes to behavioral/circadian phenotypes was unknown; a missense-bearing patient and zebrafish model linked INTS1 deficiency to disrupted sleep-wake rhythms and elevated dbh in the locus coeruleus.

   Evidence Exome sequencing, CRISPR zebrafish knockout, circadian behavior assays, qRT-PCR of dbh

   PMID:39189071

   Open questions at the time

   • Direct mechanism linking Integrator to noradrenergic circuitry unproven
   • Single-lab behavioral findings
7. 2025 Medium

   The genome-wide transcriptional consequences of INTS1 loss were unclear; RNA-seq in zebrafish mutants revealed first-intron retention and transcript readthrough extensions, establishing INTS1's role in accurate termination and 3'-end processing beyond snRNAs.

   Evidence CRISPR zebrafish knockout with global RNA-seq and bioinformatic detection of intron retention and transcript extension

   PMID:41424761

   Open questions at the time

   • Direct vs indirect transcriptional effects not separated
   • Mechanism of readthrough at specific loci not defined
8. 2025 Low

   Reported physical associations of INTS1 with HIV Tat/NF-kB p65 and with the small molecule CN-0928 raise possible roles in transcriptional regulatory complexes and condensate biology, but lack functional validation.

   Evidence Co-IP/pulldown from semen-derived extracellular vesicles with mass spectrometry; small-molecule target identification with PCBP2 level assay

   PMID:40924817 PMID:41298370

   Open questions at the time

   • Single pulldown from complex vesicle preparation without mutagenesis
   • No reconstitution or functional validation of INTS1-specific activity
   • Binding-to-function link unestablished

• The structural architecture by which INTS1 scaffolds Integrator and how it couples snRNA processing to protein-coding termination and developmental gene programs in vertebrates remain unresolved.
• No vertebrate structural model of INTS1 within the complex
• Direct catalytic vs scaffolding contributions to termination unseparated
• Tissue-specific target genes driving disease phenotypes unmapped